news Archives

• 2017-09-20
  The XXIII World Congress of Neurology(WCN2017), Kyoto, Japan
  "Modeling neurodegenerative diseases for drug discovery using human iPSCs"
• 2017-09-12
  Cold Spring Harbor Laboratory Corporate Sponsor Program "Neuropharmacology and Human Stem Cel l Models", New York, USA
  "Human pluripotent stem cells in neurological drug discovery"
• 2017-07-21
  "Analysis of neural crest cells from Charcot-Marie-Tooth disease patients demonstrates disease-relevant molecular signature"
• 2017-07-10
  "Antisense oligonucleotides reduce RNA foci in spinocerebellar ataxia 36 patient iPSCs"
• 2017-05-25
  "The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis"
• 2017-02-15
  "Proteasome impairment in neural cells derived from HMSN-P patient iPSCs"
• 2016-11-09
  "Modeling drug-induced neuropathy using human iPSCs for predictive toxicology"
• 2016-10-18
  "Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders"
• 2016-10-10
  "Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons"
• 2016-07-11
  "Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocyte"